Published in J Cell Physiol on February 01, 1999
High molecular weight FGF2: the biology of a nuclear growth factor. Cell Mol Life Sci (2009) 0.84
High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling. PLoS One (2014) 0.81
FAK mediates the inhibition of glioma cell migration by truncated 24 kDa FGF-2. Biochem Biophys Res Commun (2009) 0.81
Inhibition of tumor cell migration by LD22-4, an N-terminal fragment of 24-kDa FGF2, is mediated by Neuropilin 1. Cancer Res (2013) 0.80
Neuroprotective effects of LMW and HMW FGF2 against amyloid beta toxicity in primary cultured hippocampal neurons. Neurosci Lett (2016) 0.75
Phosphotyrosine-containing proteins are concentrated in focal adhesions and intercellular junctions in normal cells. Proc Natl Acad Sci U S A (1985) 3.76
Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation. J Cell Biol (2001) 2.04
Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. Proc Natl Acad Sci U S A (1983) 1.98
Talin is phosphorylated on tyrosine in chicken embryo fibroblasts transformed by Rous sarcoma virus. Proc Natl Acad Sci U S A (1986) 1.98
A potential basis for the thrombotic risks associated with lipoprotein(a). Nature (1989) 1.93
Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest (1989) 1.88
Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol (1982) 1.77
Distributions of vimentin and desmin in developing chick myotubes in vivo. I. Immunofluorescence study. J Cell Biol (1984) 1.65
Anomalous interaction of the acetylcholine receptor protein with the nonionic detergent Triton X-114. Proc Natl Acad Sci U S A (1985) 1.54
Immunologic relationship between platelet membrane glycoprotein GPIIb/IIIa and cell surface molecules expressed by a variety of cells. Proc Natl Acad Sci U S A (1986) 1.48
On the transfer of integral proteins into membranes. Proc Natl Acad Sci U S A (1987) 1.45
Immunocytochemical studies of cardiac myofibrillogenesis in early chick embryos. I. Presence of immunofluorescent titin spots in premyofibril stages. J Cell Biol (1987) 1.36
A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res (1995) 1.30
Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells. Mol Biol Cell (1996) 1.24
Comparative studies of the fibrinolytic activity of cultured vascular cells. Thromb Res (1979) 1.22
Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest (1984) 1.21
Disulfide bonds and the translocation of proteins across membranes. Proc Natl Acad Sci U S A (1986) 1.20
Nuclear accumulation of fibroblast growth factor receptors in human glial cells--association with cell proliferation. Oncogene (1997) 1.19
On the translocation of proteins across membranes. Proc Natl Acad Sci U S A (1987) 1.18
Immunocytochemical studies of cardiac myofibrillogenesis in early chick embryos. II. Generation of alpha-actinin dots within titin spots at the time of the first myofibril formation. J Cell Biol (1987) 1.17
Association of fibroblast growth factor receptor 1 with the adaptor protein Grb14. Characterization of a new receptor binding partner. J Biol Chem (2000) 1.16
Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. Biochemistry (1989) 1.15
Heat shock protein 27 kDa expression and phosphorylation regulates endothelial cell migration. FASEB J (1998) 1.14
Subcellular localization of sterol carrier protein-2 in rat hepatocytes: its primary localization to peroxisomes. J Cell Biol (1989) 1.12
Human endothelial cells synthesize protein S. Blood (1986) 1.12
Comparative study of the tyrosine phosphorylation of proteins in Swiss 3T3 fibroblasts stimulated by a variety of mitogenic agents. J Cell Physiol (1988) 1.11
Serum-mediated suppression of cell-associated plasminogen activator activity in cultured endothelial cells. Cell (1980) 1.11
Accelerated growth and senescence of arterial endothelial cells expressing the small molecular weight heat-shock protein HSP27. FASEB J (1995) 1.08
Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action. Brain Res Mol Brain Res (1996) 1.06
High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells--implications for the modulation of FGF-2. J Cell Biol (1995) 1.05
Distributions of vimentin and desmin in developing chick myotubes in vivo. II. Immunoelectron microscopic study. J Cell Biol (1985) 1.04
Regulation of astrocyte GFAP expression by TGF-beta1 and FGF-2. Glia (1998) 1.02
Zeugmatin: a new high molecular weight protein associated with Z lines in adult and early embryonic striated muscle. J Cell Biol (1985) 1.00
Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells. Blood (1986) 1.00
Mediation of virion penetration into vascular cells by association of basic fibroblast growth factor with herpes simplex virus type 1. Nature (1990) 0.97
Different members of the fibroblast growth factor receptor family are specific to distinct cell types in the developing chicken embryo. Dev Biol (1993) 0.94
Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex. J Clin Invest (1985) 0.94
Basolateral membrane-associated 27-kDa heat shock protein and microfilament polymerization. J Biol Chem (1997) 0.93
Plasminogen receptors, urokinase receptors, and their modulation on human endothelial cells. Blood (1988) 0.93
Disruption of microtubules inhibits the stimulation of tissue plasminogen activator expression and promotes plasminogen activator inhibitor type 1 expression in human endothelial cells. Exp Cell Res (1992) 0.92
Binding of tissue plasminogen activator to human monocytes and monocytoid cells. Blood (1991) 0.92
The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor. J Cell Physiol (1991) 0.90
The 27-kDa heat shock protein facilitates basic fibroblast growth factor release from endothelial cells. J Biol Chem (1997) 0.90
Increased release of plasminogen activator inhibitor type 2 accompanies the human mononuclear cell tissue factor response to lipopolysaccharide. Blood (1988) 0.89
Enhanced phosphorylation and dephosphorylation of a histone-like protein in response to hyperosmotic and hypoosmotic conditions. J Biol Chem (1993) 0.89
Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells. J Biol Chem (1988) 0.87
Distribution of fibroblast growth factor (FGF)-2 and FGF receptor-1 messenger RNA expression and protein presence in the mid-trimester human fetus. Pediatr Res (1996) 0.86
Intermediate filaments in skeletal and cardiac muscle tissue in embryonic and adult chicken. Ann N Y Acad Sci (1985) 0.86
Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line. J Cell Physiol (1993) 0.85
Interaction of Lp(a) with plasminogen binding sites on cells. Thromb Haemost (1995) 0.84
Human hepatoma cell line plasminogen activator. J Lab Clin Med (1983) 0.84
Regulation of plasminogen activator production by cultured endothelial cells. Ann N Y Acad Sci (1982) 0.84
Inhibition of cell migration by 24-kDa fibroblast growth factor-2 is dependent upon the estrogen receptor. J Biol Chem (2000) 0.84
Identification of a protein transiently phosphorylated by activators of endothelial cell function as the heat-shock protein HSP27. A possible role for protein kinase C. Biochem J (1992) 0.82
Fluid shear stress induces the phosphorylation of small heat shock proteins in vascular endothelial cells. Am J Physiol (1996) 0.81
Specificity of the thrombin-induced release of tissue plasminogen activator from cultured human endothelial cells. Thromb Haemost (1986) 0.81
Defect in polyamine metabolism in a BHK cell mutant temperature-sensitive for rRNA maturation. J Cell Physiol (1979) 0.79
Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cells. Biochim Biophys Acta (1982) 0.78
Targeting of tissue plasminogen activator into the regulated secretory pathway of neuroendocrine cells. Brain Res (1999) 0.76
Stimulation of tissue plasminogen activator production by retinoic acid: synergistic effect on protein kinase C-mediated activation. Blood (1992) 0.76
Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines. Clin Exp Metastasis (1997) 0.76
Basic fibroblast growth factor in cells derived from Dupuytren's contracture: synthesis, presence, and implications for treatment of the disease. J Hand Surg Am (1992) 0.75
Thrombin and the thrombin-thrombomodulin complex interaction with plasminogen activator inhibitor type-1. Blood Coagul Fibrinolysis (1991) 0.75
[Minimally-invasive method of treating nephroptosis]. Urol Nefrol (Mosk) (2002) 0.75
[Emergency care in acute pyelonephritis]. Sov Med (1978) 0.75
[Objective control over the degree of tension of the pubic-vaginal ligatures in transcutaneous retropubic urethrocervicopexy in women with stress urinary incontinence]. Urologiia (2001) 0.75
Phosphotyrosine-containing proteins are concentrated in differentiating cells during chicken embryonic development. Growth Factors (1993) 0.75
Demonstration of single chain urokinase-type plasminogen activator on human platelet membrane. Blood (1989) 0.75
Neuronal differentiation factor TA20--homology with cytochrome b. Neuroreport (1998) 0.75
[Diagnostic scale of infravesical obstruction in patients d with benign prostatic hyperplasia]. Urol Nefrol (Mosk) (1999) 0.75